T. Itoyama et al., PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - IMMUNOPHENOTYPIC, VIROLOGICAL, AND CYTOGENETIC FINDINGS OF 3 PATIENTS WITHOUT IMMUNE DEFECTS, Cancer, 73(2), 1994, pp. 455-463
Background. Primary central nervous system (PCNS) lymphoma is a relati
vely rare disease, but an increasing incidence is reported. The Epstei
n-Barr virus (EBV), which is often found in lymphomas of immunocomprom
ised patients, has been implicated in the development of lymphomas. Ma
ny cytogenetic analyses of nodal B cell lymphomas have been performed,
but few studies on PCNs lymphomas have been reported. Methods. The de
tection of EBV genome using the polymerase chain reaction (PCR) method
and cytogenetic studies were performed, in addition to histopathologi
c and immunophenotypic approaches in biopsied tissue from three patien
ts with PCNs lymphoma. Immunosuppressive states and exposure to mutage
ns were not clear in all patients. Results. Histopathologic examinatio
n disclosed a diffuse type of malignant lymphoma in all patients. Immu
nophenotypic studies revealed B cell phenotype in all patients, two of
whom showed positive reaction for CD5. The PCR method revealed no inv
olvement of EBV genome in tumors in any patients. The cytogenetic stud
y showed clonal chromosome abnormalities in all patients, and abnormal
ities of chromosome 1 (1q21), 6 (-6, 6q15 and 6q21), 7 (-7 and 7p15),
and 14 (14q24 and 14q32) were prominent. The t(6;14)tq15;q32) observed
in Patient 1 is the first case to be reported in human de novo lympho
ma. Conclusions. These findings indicate that the causative role of EB
V in PCNS lymphoma without immune defects is not clear. The cytogeneti
c findings were similar to those observed in nodal B-cell lymphoma, su
ggesting that the origin of PCNs lymphoma cells does not differ from n
odal B cell lymphoma cells cytogenetically.